Jade Biosciences
2 known investors
Jade Biosciences is a clinical-stage biotech company developing antibody-based therapies for autoimmune diseases, with a lead candidate (JADE101) targeting the cytokine APRIL for the treatment of immunoglobulin A nephropathy (IgAN). Its programs build on discovery-stage assets licensed from Paragon Therapeutics.
Investors · 2
Frequently asked questions
- What does Jade Biosciences do?
- Jade Biosciences is a clinical-stage biotech company developing antibody-based therapies for autoimmune diseases, with a lead candidate (JADE101) targeting the cytokine APRIL for the treatment of immunoglobulin A nephropathy (IgAN). Its programs build on discovery-stage assets licensed from Paragon Therapeutics.
- Who are Jade Biosciences's investors?
- Jade Biosciences's investors include Foresite Capital, Frazier Life Sciences.